Amalgamated Bank’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Amalgamated Bank’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,259	Closed	-$300K	–	1743
2020 Q1	$300K	Sell	6,259 -271	-4%	-$12.6K	0.01%	1153
2019 Q4	$306K	Buy	+6,530	New	+$289K	0.01%	1401

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Amalgamated Bank's RARX Position: Q2 2020 in Review

Amalgamated Bank sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 6,259 shares — an estimated $300K sold.

Amalgamated Bank first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $306K in Q4 2019. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Amalgamated Bank reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Amalgamated Bank sold 6,259 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $300K.
Amalgamated Bank first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Amalgamated Bank's Ra Pharmaceuticals, Inc. Common Stock position peaked at $306K in Q4 2019.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Amalgamated Bank's 13F filing for Q2 2020, filed 10 Aug 2020.